ANKARA (Reuters) – Turkey on Friday began administering COVID-19 injections from Pfizer (NYSE 🙂 and BioNTech, introducing a second vaccine into its campaign as new cases reached record levels. Turkey has so far delivered nearly 16.6 million doses of the vaccine developed by China’s Sinovac Biotech, including two injections each for around 7.1 million people and one vaccine each for around 2.4 million people. . So far, the deployment has included people over 60, health personnel and other priority groups. A total of 2.8 million doses of the Pfizer vaccine have reached Turkey, and that number is expected to reach 4.5 million in the coming days, Health Minister Fahrettin Koca said on Wednesday. People can choose which vaccine they would like to receive when their turn comes, Koca said, adding that the goal is to vaccinate the majority of the population by June. Emre Yavuz said he and his wife received the Pfizer / BioNTech vaccine because their daughter is studying in Europe, which he said may not allow entry for those receiving the Sinovac vaccine. “There is a debate in the European Union about whether to accept this (Sinovac) or not. Therefore, I chose this to be on the safe side,” he said, after receiving his first injection at Ankara City Hospital. Turkey recently imposed new weekend closures in most provinces as cases hit record highs across the country. 42,308 new cases were registered on Friday, the highest level since the start of the pandemic. The total number of cases stood at over 3.4 million as of Friday, with a death toll at 31,892. Turkey currently ranks fifth globally in daily cases based on a seven-day average, according to a Reuters tally.
Disclaimer: Fusion Media wishes to remind you that the data contained on this website is not necessarily accurate or in real time. All CFDs (stocks, indices, futures) and Forex prices are not provided by exchanges but by market makers, so the prices may not be accurate and may differ from the actual market price, which means that prices are indicative and not appropriate for commercial purposes. Therefore, Fusion Media assumes no responsibility for any business losses you may incur as a result of the use of this data. Fusion Media or anyone involved with Fusion Media will not accept any responsibility for loss or damage as a result of reliance on information, including data, quotes, charts, and buy / sell signals contained on this website. Be fully informed about the risks and costs associated with trading the financial markets, it is one of the riskiest forms of investment possible.